NRC Health Reports Q1 Net Income Down 44% Amid Higher Compensation Costs, Announces $60M Share Repurchase
Summary
NRC Health reported a significant 44% decline in Q1 net income and EPS, primarily due to increased executive compensation, despite modest revenue growth. The company also authorized a new $60 million share repurchase program.
Key Events
-
Q1 Net Income & EPS Decline
Net income decreased 44% to $3.222 million, and basic EPS fell 44% to $0.14, compared to the prior year, primarily due to increased operating expenses.
-
Revenue Growth
Revenue increased by 3.7% to $34.803 million, marking continued growth in subscription-based services.
-
Increased Operating Expenses
Selling, general, and administrative expenses rose 30% to $13.419 million, primarily due to $1.4 million higher stock-based compensation and $0.5 million in executive salary expense.
-
Strong TRCV Growth
Total Recurring Contract Value (TRCV) grew 13.2% to $152.070 million, indicating positive future revenue trends.
Analysis
NRC Health's first-quarter results, previously announced in an 8-K on April 28, 2026, show a substantial decrease in profitability, with net income and EPS falling by 44% year-over-year. This decline was largely driven by a 30% increase in selling, general, and administrative expenses, which included higher stock-based compensation and executive salaries. While revenue saw modest growth and Total Recurring Contract Value (TRCV) increased by 13.2%, indicating future revenue potential, the immediate impact on earnings is a concern. The company also detailed a new $60 million share repurchase program, representing a significant commitment to returning capital to shareholders, which provides a positive counter-signal to the earnings weakness. The subsequent event regarding executive equity awards and tax bonuses, also previously disclosed in an 8-K and 10-K/A on April 28, 2026, is expected to result in a $9.4 million expense in Q2 2026. Investors should monitor the impact of these compensation changes on future profitability and the execution of the share repurchase program.
At the time of this filing, NRC was trading at $18.29 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $400.8M. The 52-week trading range was $11.01 to $22.79. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.